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Safety of Universal Provision of Iron through
Home Fortification of Complementary Foods
in Malaria-Endemic Areas1,2
Kathryn G. Dewey* and Lacey M. Baldiviez
Department of Nutrition and Program in International and Community Nutrition, University of California, Davis, Davis, CA
ABSTRACT
Home fortification of complementary foods with iron and other micronutrients is a low-cost strategy for filling nutrient gaps in the diets of infants
and young children, but there has been uncertainty about the safety of universal provision of iron via home fortification in malaria-endemic areas.
Based on the current understanding of the potential mechanisms of adverse effects of iron, the risk can probably be minimized by using the
lowest possible efficacious dose of iron, preferably delivered in small amounts throughout the day with food, to minimize spikes in plasma
nontransferrin-bound iron and large amounts of unabsorbed iron in the gastrointestinal tract. Results from 6 home fortification studies in malaria-
endemic areas showed no increased risk of morbidity (including malaria), but these studies were not powered to rule out a modest increase in
the risk of severe adverse events. At present, the safest option is to implement home fortification in the context of comprehensive malaria control
strategies, as recommended in recent WHO guidelines. Adv. Nutr. 3: 555–559, 2012.
Introduction
In low-income populations, iron deficiency is generally very
common during the period of complementary feeding, e.g.,
from 6 to 24 mo of age, as described in a companion paper
(1). Much of this is attributable to very low intake of absorb-
able iron from complementary foods, relative to requirements.
Thus, strategies to increase iron intake during this period are
essential to avoid the deleterious effects of iron deficiency and
iron-deficiency anemia on behavioral development and other
outcomes. The question is whether it is better to take a tar-
geted approach by providing iron only to those who have al-
ready become iron deficient, potentially avoiding deleterious
effects of iron on those who are iron replete (2), or to provide
iron to all children within a certain age range (“universal” or
“blanket” provision) regardless of their iron status.
Although targeted provision of iron may be attractive
from a biological perspective, there are several practical con-
siderations that limit feasibility. Apart from the issue of find-
ing an appropriate indicator of iron status that can be
inexpensively and easily measured, the targeted approach re-
quires that iron deficiency or anemia be detected via screen-
ing before iron is provided to a given child. Some children
will therefore be iron deficient for quite some time before
they receive additional iron, depending on the frequency
of screening, which means that the critical window for pre-
venting the adverse effects of iron deficiency may be missed.
The targeted approach also complicates the situation with
respect to addressing other micronutrient and macronutri-
ent deficiencies during the period of complementary feeding
because it would require that fortified products designed for
universal use would not include iron, even though iron is
usually the most limiting nutrient at this age.
In recent years, programmatic priorities have shifted to-
ward taking a comprehensive approach to improving nutrit-
ion in infants and young children rather than focusing
predominantly on programs that provide just 1 key nutrient
at a time (e.g., iron supplementation). Improving comple-
mentary feeding involves a wide range of strategies to tackle
the many dimensions of suboptimal feeding practices and
dietary inadequacies (3). Within this spectrum, a number
of options to improve iron content and bioavailability of
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complementary foods have been explored. Because these
strategies are generally designed to prevent deficiency
(rather to treat deficiency), they are mainly intended for uni-
versal implementation. Thus, it is important to evaluate the
safety of universal provision of iron through such ap-
proaches, particularly in malaria-endemic areas. This paper
focused on home fortification because this approach is cur-
rently being scaled up in several countries and is likely to be
the most cost-effective strategy for improving nutrient den-
sity of complementary foods (4).
Biological plausibility for safety of home
fortification with iron
Theoretical considerations regarding safety based on the
amount of iron provided per meal. Iron content of comple-
mentary foods can be increased via several different strategies
including a) dietary modification (e.g., increased intake of
flesh foods and use of traditional food-processing techniques
to enhance iron absorption from plant-based foods), b) iron-
fortified processed complementary foods, and c) use of home
fortification products [e.g., micronutrient powders (MNP)3
or lipid-based nutrient supplements (LNS)]. Compared with
the use of iron supplements (e.g., liquid iron drops), which
are typically given between meals, the 3 strategies above all in-
volve the provision of iron with food, which is known to slow
iron absorption (5) and therefore modulate the potential phys-
iological impact of the “bolus” of iron delivered.
Dietary modification strategies have generally had a rela-
tively modest impact on iron status, mainly because the in-
crease in iron content or bioavailability of complementary
foods that is achievable by these means is limited (3). The
safety of dietary modification strategies has not been ques-
tioned, however. Of the 2 strategies that involve fortification,
commercially processed complementary foods can be forti-
fied to provide the recommended nutrient intake (RNI) of
iron (e.g., 9 mg/d at 7–12 mo of age, assuming 10% bioavail-
ability (6)) in each daily ration, which is usually distributed
across 2–3 meals per day. Each meal would thus provide 3–
4.5 mg of iron if the full daily ration is consumed. In the state-
ment emerging from the WHO technical consultation in
2006 (7), processed complementary foods fortified with
iron were considered to be safe because they provide a phys-
iological dose of iron distributed throughout the day, “which
avoids the adverse gastrointestinal and morbidity effects of a
bolus dose.” However, the actual intake of iron from pro-
cessed complementary foods may vary widely because of a
large range in intake of the product across individuals
(from as little as 10 g/d to as much as 100 g/d of the dry pro-
duct). Efficacy with regard to improved iron status and re-
duced anemia may thus be less consistent than is achievable
with strategies (such as home fortification) that can better en-
sure consumption of the intended dose of iron each day (3).
Iron content of home fortification products is typically
w1 RNI (e.g., 9–12.5 mg/d; the RNI varies depending on
expected bioavailability of iron). If the entire daily dose is
mixed with a single meal (as is usually the case with MNP),
then the “bolus” of iron would be similar to that used in
the iron supplementation trial in Pemba in which adverse ef-
fects were observed (8). For this reason, the statement emerg-
ing from the WHO technical consultation (7) advised that
home fortification products “should not be used in ma-
laria-endemic areas” (note that this statement has now been
superseded by the recently published WHO guidelines on
use of multiple micronutrient powders for home fortification
(9) that state that such products can be used in malaria-en-
demic areas if “implemented in conjunction with measures
to prevent, diagnose and treat malaria”).
However, if the daily dose of the home fortification pro-
duct is divided between $2 meals, then the amount of iron
consumed per meal would be similar to that provided by
processed fortified complementary foods. For example, if
the daily ration of LNS used for home fortification includes
9 mg of iron and is divided between 2 meals, the iron con-
sumed per meal would be 4.5 mg. Current research trials be-
ing conducted in Africa as part of the International Lipid-
based Nutrient Supplements Project (10) are using LNS
with a reduced amount of iron (6 mg/d), with participants
being advised to divide the dose between 2 meals, thus de-
livering w3 mg of iron per meal. Thus, home fortification
can be designed to be as “safe” (theoretically) as processed
fortified complementary foods. One advantage of the
home fortification approach is that each child receives the
intended amount of iron via the home fortification product,
regardless of the amount of complementary food consumed.
Hypothesized mechanisms for the adverse effects of iron
in malaria-endemic areas and implications regarding
safety of home fortification. To evaluate whether home for-
tification with iron-containing products is likely to be safe in
malaria-endemic areas, it is useful to consider the hypothe-
sized mechanisms for the adverse effects of iron. At present,
our understanding of these mechanisms is incomplete. Hurrell
(5) describes 2 likely “candidate” pathways by which excess
iron may be harmful. The first is that a large bolus of iron
triggers a spike in plasma nontransferrin-bound iron
(NTBI), which may induce cell damage via reactive oxygen
radicals and increase inflammation. This may stimulate ex-
pression of endothelial adhesion molecules in capillaries
and lead to increased sequestration of red bloods infected
by the malaria parasite, impairing function of the microvas-
culature. NTBI entering the liver may also facilitate the pen-
etration of hepatocytes by malaria sporozoites. The second
hypothesized pathway is that iron stimulates growth of enteric
pathogenic organisms, which may impair the innate immune
response of the gastrointestinal tract and lead to bacterial in-
vasion through the gut into the systemic circulation, causing
bacteremia and septicemia. Ironmay influence morbidity and
mortality by either, both, or perhaps neither of these routes.
The first of these 2 hypothetical pathways is illustrated in
Figure 1. Because the rate of iron influx into plasma exceeds
the rate at which iron binds to transferrin, iron can appear as
3 Abbreviations used: LNS, lipid-based nutrient supplement; MNP, micronutrient powder;
NTBI, nontransferrin-bound iron; RNI, recommended nutrient intake.
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NTBI in the plasma. NTBI is thought to contribute to iron
toxicity due to its role in the Haber-Weiss and Fenton reac-
tions that generate reactive oxygen species. Reactive oxygen
species induce cell damage through the oxidation of lipids,
proteins, and DNA.
Malaria may exacerbate the damage due to NTBI. Iron is
absorbed through the gut and enters the hepatic portal sys-
tem. Thus, the concentration of NTBI reaching the liver is
expected to be far higher than the concentration detected
in plasma. Immature forms of the malaria parasite, sporozo-
ites, are introduced into the circulation by the mosquito vec-
tor and occupy the liver. An increased supply of iron in the
liver may facilitate penetration of hepatocytes by sporozo-
ites, leading to the development of merozoites, the form of
malaria parasite that infects red blood cells.
In severe cases of malaria, parasitized red blood cells adhere
to adhesion molecules expressed on the surface of endothelial
cells lining blood vessels. Up-regulation of adhesion molecules
on the endothelia of the microvasculature occurs in response
to proinflammatory mediators during an episode of malaria.
After 24–48 h in the circulation, parasitized red blood cells be-
gin to express “knobs” capable of binding adhesion molecules
and are sequestered from circulation. Sequestration of infected
red blood cells prevents removal by the spleen and occludes
the microvasculature, leading to the symptoms of severe ma-
laria. Therefore, if excess iron increases the number of mero-
zoites and infected red blood cells, this would increase the risk
of damage to the microvasculature.
The magnitude of the effects illustrated in Figure 1 is
likely to be related to the amount of NTBI entering the
plasma, which depends on the amount of iron absorbed af-
ter ingestion. The total amount of iron absorbed will be
lower under certain conditions, such as when a) the dose
of iron is relatively low; b) iron is consumed with food,
which reduces absorption by as much as two thirds (5); c)
the individual is iron replete; and d) there is clinical or sub-
clinical infection or inflammation, which reduces iron ab-
sorption. Because home fortification can be designed to
provide relatively small amounts of iron per meal and the
iron is always ingested with food, it should be possible to
minimize the effects illustrated in Figure 1.
However, strategies that prevent large spikes in absorbed
iron may not be sufficient to eliminate all of the risks associ-
ated with excess dietary iron. As illustrated in Figure 2, the
unabsorbed iron remaining in the gastrointestinal tract may
foster the growth of less beneficial, even pathogenic, bacteria
in the colon. Iron acquisition is essential for the growth of en-
teric pathogenic organisms such as Salmonella, Shigella, and
pathogenic Escherichia coli, whereas beneficial gut bacteria
such as lactobacilli and bifidobacteria do not require an exter-
nal source of iron. Thus, unabsorbed iron may mediate the
growth of enteric pathogenic bacteria and impede the com-
petitive inhibition of pathogenic strains by beneficial strains.
Evidence supporting this phenomenon is provided by a recent
randomized, controlled trial among school-age children in
Côte d’Ivoire in which iron-fortified biscuits provided for 6
mo resulted in a more unfavorable ratio of fecal enterobacte-
ria to bifidobacteria and lactobacilli and an increase in a
marker of gut inflammation (11). Gastrointestinal tissue
damage may be a gateway for pathogenic organisms to enter
the circulation. In combinationwith malaria, which may itself
alter gut permeability because intestinal villi are favored sites
of sequestration for parasitized red blood cells, excess iron in
the gut could increase the risk of bacteremia. This is sup-
ported by the fact that one of the complications of severe ma-
laria is non-typhi Salmonella bacteremia (12).
These 2 hypothesized pathways—spikes in NTBI and in-
creased growth of enteric pathogens—may jointly contrib-
ute to the adverse effects of iron in malaria-endemic areas,
as illustrated in Figure 3. It is noteworthy that the adverse
effects observed in the Pemba trial were related to the sever-
ity of malaria (i.e., hospitalization) and overall mortality, not
necessarily an increase in the incidence of malaria, which is
consistent with the endpoints shown in Figure 3.
Figure 1 Postulated effect of NTBI on severity of malaria.
ICAM-1, intercellular adhesion molecule; iRBC, infected red
blood cell; NTBI, nontransferrin-bound iron; PfEMR-1,
Plasmodium falciparum erythrocyte membrane protein 1; ROS,
reactive oxygen species. Adapted from Reference 5 with
permission.
Figure 2 Postulated effect of supplemental iron on
bacteremia. iRBC, infected red blood cell. Adapted from
Reference 5 with permission.
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As mentioned previously, our understanding of the
mechanisms underlying the adverse effects of excess iron
is still very incomplete. If, however, the pathways shown
in Figure 3 are at least part of the picture, the implication
is that interventions to improve the iron status of young
children should aim at the lowest possible efficacious dose
of iron, preferably delivered in small amounts throughout
the day with food, to minimize spikes in NTBI and large
amounts of unabsorbed iron in the gastrointestinal tract.
Evidence regarding safety of home fortification
with iron
Empirical evidence regarding the safety of home fortification
of complementary foods in malaria-endemic areas is very
limited. We were able to identify only 6 relevant studies
(13–17), 3 of which have not yet been fully published. De-
tails of the 3 published randomized, controlled trials were
described in a previous review on home fortification (4).
These include a trial using crushable micronutrient tablets
in South Africa (13), MNP in Pakistan (14), and 3 different
types of home fortification products (MNP, crushable tab-
lets, and LNS) in Ghana (15). Malaria was not a primary
outcome in any of these studies, but the percentage of
days with fever (often caused by malaria) was assessed in
South Africa and Ghana. In South Africa (N = 265), there
were no significant differences in the percentage of children
with fever on the day of contact with the health worker (dur-
ing weekly morbidity surveillance over the 6-mo interven-
tion period) among the 4 intervention groups: placebo,
13.4%; daily iron (10 mg/d), 10.1%; daily multiple micronu-
trients, 10.6%; and weekly multiple micronutrients (contain-
ing 20 mg of iron per week), 12.2%. Similarly, in Ghana (N =
409), there were no significant differences among any of the 3
intervention groups (who received 9–12.5 mg iron/d) and the
nonintervention group in the percentage of children with fe-
ver during the 1-wk period before the end of the 6-mo inter-
vention period or in the mean percentage of days with fever
during the intervention among the 3 intervention groups
(3.3% for MNP, 5.3% for crushable tablets, and 4.3% for
LNS). These 2 studies also showed no significant differences
in prevalence of diarrhea among the 3 intervention groups.
The trial in Pakistan, conducted with 75 infants with a history
of diarrhea, showed a significant reduction in longitudinal
prevalence of diarrhea in the MNP group (15%) compared
with the placebo group (26%) (P = 0.009) after 2 months
of supplementation.
In the 3 other trials (in Kenya, Ghana, and Malawi), ma-
laria incidence was documented. In western Kenya, a clus-
ter-randomized trial was conducted to assess the impact of
community-based marketing of MNP (Sprinkles, Ped-Med,
Ltd., Toronto, Canada) (16). Sixty villages were randomly as-
signed to the intervention or control group; in the interven-
tion villages, community vendors sold Sprinkles targeted at
children between 6 and 59 mo of age. The baseline survey
was conducted in July 2007, the intervention was imple-
mented 3 mo later, and the follow-up survey (N = 862) was
conducted in March 2008; after that, the project package
was implemented in the control villages. The surveys included
children 6–35 mo of age. During biweekly household visits in
the intervention villages, 33% of households had purchased
Sprinkles in the previous 2 wk; average weekly intake was
0.9 sachets/wk, contributing w11 mg of iron per week. De-
spite this relatively small increase in iron intake, there were
significant differences in the prevalence of iron deficiency
and in mean hemoglobin values between intervention and
control villages. There was no significant difference in the
rate of malaria parasitemia between groups.
In Ghana, a randomized, controlled trial was conducted
to determine the impact of providing iron in MNP on the
incidence and severity of malaria in an area with a high bur-
den of malaria (17). In total, 1956 children 6–35 mo of age
were randomized to receive MNP (Sprinkles) daily for 5 mo;
1 group received MNP with the usual amount (12.5 mg) of
iron (as ferrous fumarate), and the other group received
MNP with no iron. Malaria status was assessed at weekly
home visits. There were no significant differences between
groups in the incidence of malaria or severe adverse out-
comes such as cerebral malaria and hospitalizations.
The intervention in Malawi was of longer duration (12
mo) than the intervention period in the 2 trials described
above (5–6 mo) and involved the delivery of iron via LNS
rather than MNP. The Lungwena Child Nutrition Interven-
tion-5 study was a randomized intervention trial in which
infants (N = 840) were randomly assigned at 6 mo of age
to 1 of 4 intervention groups: a) LNS (the usual formulation
that includes milk powder), b) LNS with soy in place of milk
powder, c) fortified maize-soy flour (isocaloric daily dose),
or d) control (delayed intervention). Iron content of the
products was 6 mg/d in LNS and 5.5 mg/d in the maize-
soy flour. Morbidity surveillance was conducted weekly.
There were no significant differences among groups in the
percentage of children with confirmed malaria during the
12-mo intervention period (excluding cases of malaria at en-
rollment) or in the mean percentage of days with fever,
cough, or diarrhea (K. Maleta, personal communication).
Figure 3 Pathways that may jointly contribute to adverse
effects of supplemental iron in malaria-endemic areas. NTBI,
nontransferrin-bound iron; ROS, reactive oxygen species.
Adapted from Reference 5 with permission.
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The lack of adverse effects in the cited trials is somewhat re-
assuring, but for several reasons, it is difficult to draw definitive
conclusions about safety. First, some of the interventions were
of relatively short duration (<6 mo), which limits the ability to
detect effects that may be cumulative or not apparent until the
average iron status reaches a certain threshold. Second, the dose
of iron in some of the trials was modest (especially the market-
ing trial in Kenya), so generalizations regarding the safety of
higher doses may not be warranted. Third, none of the studies
have so far reported on whether initial iron status has an influ-
ence on treatment effects. Given that the Pemba trial found
that children with higher iron status were more vulnerable to
adverse effects of iron supplementation [in the subsample anal-
yses (8)], it is important to conduct subgroup analyses if sam-
ple size permits. Last, even the largest of these trials, the study
in Ghana with almost 2000 children, is still not sufficiently
powered to detect relatively small effects on adverse outcomes
such as were seen in the Pemba trial.
Conclusions
Home fortification of complementary foods is gaining visi-
bility as an effective approach for increasing intake of iron
and other micronutrients by infants and young children at
risk of nutrient deficiencies. It is probably a safer option
than iron supplements given without food, although evi-
dence directly comparing the safety of these 2 approaches
in malaria-endemic areas is lacking. Results from 6 home
fortification studies in malaria-endemic areas (some not
yet published) showed no increased risk of adverse effects.
Most of these studies, however, had small to moderate sam-
ple sizes, so severe adverse events could not be adequately as-
sessed. There is also a lack of information on the potential
modifying effect of initial iron status on treatment effects.
Although the evidence to date suggests that home fortifica-
tion with iron in malaria-endemic areas is safe, additional
research would be valuable.
However, it is very challenging, if not impossible, to ob-
tain conclusive evidence of the safety of home fortification
in malaria-endemic areas. Severe adverse events associated
with iron consumption are likely only seen where infectious
disease control is lacking, yet it would be unethical in this
type of setting to conduct studies without providing any ser-
vices to monitor and treat infectious disease, including ma-
laria. A huge sample size would be required to rule out a
modest increase in severe adverse effects. For the moment,
the safest option is to deliver home fortificants in the context
of comprehensive malaria control strategies, as recommen-
ded in the recent WHO guidelines on the use of MNPs
(9). The evidence to date indicates that universal provision
of iron is safe in populations with adequate malaria surveil-
lance and treatment (18). As home fortification programs
are rolled out, it would be highly desirable to structure pro-
gram implementation to facilitate rigorous evaluation of the
effectiveness and safety of such interventions. This may help
to answer the remaining question of how to safely ensure ad-
equate iron status of infants and young children in popula-
tions without adequate malaria surveillance and treatment.
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